Carbinoxamine and Pseudoephedrine Extend... Clinical Trials

• Study Evaluating LAMICTAL Extended-release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
  ClinicalTrials.gov Identifier: NCT00113165 - Active, not recruiting
  Epilepsy
  
• Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy
  ClinicalTrials.gov Identifier: NCT00355082 - Active, not recruiting
  Epilepsy, Partial
  
• Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-Release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain
  ClinicalTrials.gov Identifier: NCT00410943 - Active, not recruiting
  Pain
  
• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00348309 - Recruiting
  Alzheimer Disease
  
• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00348140 - Recruiting
  Alzheimer's Disease
  
• Rosiglitazone (Extended Release Tablets) Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00428090 - Recruiting
  Alzheimer's Disease
  
• Effect of Niacin Extended Release and Lovastatin tablets on Walking in Patients with Intermittent Claudication (ICPOP)
  ClinicalTrials.gov Identifier: NCT00062556 - Completed
  Intermittent Claudication; Peripheral Vascular Disease
  
• A Study to Evaluate LAMICTAL Extended-release Therapy in Patients with Primary Generalized Tonic Clonic Seizures
  ClinicalTrials.gov Identifier: NCT00104416 - Active, not recruiting
  Tonic-Clonic Seizures; Epilepsy
  
• RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
  ClinicalTrials.gov Identifier: NCT00314860 - Active, not recruiting
  Restless Legs Syndrome
  
• Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy:
  ClinicalTrials.gov Identifier: NCT00356018 - Not yet recruiting
  Epilepsy
  
• Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects
  ClinicalTrials.gov Identifier: NCT00255528 - Completed
  Hypertension
  
• To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With High Cholesterol.
  ClinicalTrials.gov Identifier: NCT00271817 - Recruiting
  Hypercholesterolemia
  
• The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in Adolescents
  ClinicalTrials.gov Identifier: NCT00195741 - Completed
  Migraine
  
• A Within-Subject Cross-Over Comparison Between Immediate Release and Extended Release Adderall
  ClinicalTrials.gov Identifier: NCT00468143 - Not yet recruiting
  Attention Deficit Hyperactivity Disorder
  
• Tolerability of MK0524A Versus Niacin Extended-Release
  ClinicalTrials.gov Identifier: NCT00378833 - Active, not recruiting
  Hypercholesterolemia; Hyperlipidemia
  
• Effect of an Investigational Compound on Tolerability of Extended Release Niacin
  ClinicalTrials.gov Identifier: NCT00376584 - Active, not recruiting
  Hypercholesteremia; Hyperlipidemia
  
• Oxycodone-Naloxone Prolonged Release Tablets in Relieving Opioid-Related Constipation
  ClinicalTrials.gov Identifier: NCT00412100 - Active, not recruiting
  Pain
  
• Study Evaluating Venlafaxine Extended Release in Elderly Depressed Patients
  ClinicalTrials.gov Identifier: NCT00247429 - Active, not recruiting
  Depressive Syndrome; Anxiety
  
• Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00195767 - Completed
  Bipolar I Disorder, Manic or Mixed
  
• Pioglitazone Vs Placebo in Combination With Niacin Extended Release on Low HDL
  ClinicalTrials.gov Identifier: NCT00300365 - Recruiting
  Metabolic Syndrome
  
• Study of Extended Release Niacin/Laropiprant on Lipids
  ClinicalTrials.gov Identifier: NCT00479388 - Recruiting
  Primary Hypercholesterolemia; Mixed Dyslipidemia
  
• Evaluate Efficacy and Safety of Tolterodine Extended Release Capsule Compared with Tolterodine Immediate Release Tablet in Patients with Symptoms of Overactive Bladder
  ClinicalTrials.gov Identifier: NCT00139724 - Completed
  Overactive bladder
  
• A Repeated Dose Study of the Metabolism and Action Evaluation of OROS Hydromorphone HCI (Slow Release) Tablets in Patients With Chronic Pain
  ClinicalTrials.gov Identifier: NCT00410878 - Active, not recruiting
  Analgesics, Opioid.; Pain
  
• An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00060905 - Completed
  Bipolar Disorder
  
• Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients with Dyslipidemia: A Dose-Ranging Study - SEACOAST
  ClinicalTrials.gov Identifier: NCT00082251 - Completed
  Hypercholesterolemia
  
• Open Label Study of Lithium Plus Extended-Release Carbamazepine (ERC-CBZ) for Rapid Cycling Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00325286 - Active, not recruiting
  Bipolar Disorder
  
• A Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-Release Paliperidone in Subjects With Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00299715 - Active, not recruiting
  Bipolar Disorder; Mood Disorders
  
• An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00067262 - Completed
  Bipolar Disorder
  
• PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes
  ClinicalTrials.gov Identifier: NCT00153062 - Active, not recruiting
  Cerebrovascular Accident
  
• Depakote ER plus an atypical antipsychotic vs. an atypical antipsychotic alone in the treatment of schizophrenia
  ClinicalTrials.gov Identifier: NCT00073164 - Completed
  Schizophrenia
  
• Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects during the Maintenance Phase of Bipolar Illness
  ClinicalTrials.gov Identifier: NCT00071253 - Terminated
  Bipolar Disorder
  
• Study to Measure the Safety of Paliperidone ER (Extended-Release) in Patients With Liver Disease
  ClinicalTrials.gov Identifier: NCT00535145 - Recruiting
  Schizophrenia; Psychotic Disorders; Schizoaffective Disorder
  
• 3 Fixed Dosages of Extended Release OROS Paliperidone and Olanzapine in the Treatment of Subjects with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00078039 - Active, not recruiting
  Schizophrenia
  
• Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00511953 - Active, not recruiting
  Hot Flashes
  
• Extended Release OROS Paliperidone in Treatment of Schizophrenia (double blind, placebo-controlled trial, with Olanzapine arm)
  ClinicalTrials.gov Identifier: NCT00083668 - Active, not recruiting
  Schizophrenia
  
• Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients with Dyslipidemia (OCEANS)
  ClinicalTrials.gov Identifier: NCT00080275 - Completed
  Hypercholesterolemia
  
• A Safety and Effectiveness Study of Methylphenidate HCl Extended-Release Tablets in Adults With Attention Deficit Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00326391 - Completed
  Attention Deficit Disorder With Hyperactivity
  
• Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis
  ClinicalTrials.gov Identifier: NCT00397657 - Recruiting
  Atherosclerosis
  
• Lamotrigine Extended-Release in Elderly Patients With Epilepsy
  ClinicalTrials.gov Identifier: NCT00516139 - Recruiting
  Epilepsy
  
• Improving Hispanic Retention in Antidepressant Therapy
  ClinicalTrials.gov Identifier: NCT00057642 - Active, not recruiting
  Depression; Depressive Disorder
  
• A Study of the Efficacy and Safety of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00524043 - Recruiting
  Schizophrenia
  
• Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-Release (ER) for Hypertension
  ClinicalTrials.gov Identifier: NCT00547300 - Recruiting
  Hypertension
  
• Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aerug
  ClinicalTrials.gov Identifier: NCT00481689 - Completed
  Urinary Tract Infections
  
• A Trial to Explore the Tolerability, Safety and Effectiveness of Paliperidone ER (Extended Release) Flexible Dosing in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00460512 - Recruiting
  Schizophrenia
  
• A Study To Look At The Starting Dose Of Ropinirole Immediate Release Tablets In Young Patients With Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00140712 - Recruiting
  Restless Legs Syndrome
  
• Peg-Intron/Ribavirin in G 1 HCV for Non-Extended Versus 24 Week Extended Treatment After 24 Weeks (Study P04144AM)
  ClinicalTrials.gov Identifier: NCT00202839 - Active, not recruiting
  Hepatitis C, Chronic
  
• Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia
  ClinicalTrials.gov Identifier: NCT00315900 - Recruiting
  Agitation; Dementia
  
• A Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent Patients.
  ClinicalTrials.gov Identifier: NCT00518323 - Recruiting
  Schizophrenia
  
• A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-Release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00309686 - Active, not recruiting
  Affective Psychosis, Bipolar; Bipolar Disorder; Mania
  
• A Trial to Explore the Tolerability, Safety and Treatment Response of the Antipsychotic Paliperidone ER (Extended Release) Using Flexible Dosing in Patients With Acute Schizophrenia
  ClinicalTrials.gov Identifier: NCT00566631 - Recruiting
  Schizophrenia
  
• A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-Release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00309699 - Active, not recruiting
  Bipolar Disorder; Mood Disorders
  
• Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers Disease
  ClinicalTrials.gov Identifier: NCT00334568 - Terminated
  Alzheimers Disease
  
• Exercise vs. Extended-Release Niacin in Patients With Coronary Heart Disease and Low HDL Cholesterol: Effect on Lipid Profile and Endothelial Function
  ClinicalTrials.gov Identifier: NCT00298909 - Recruiting
  Coronary Disease; Hypolipoproteinemia
  
• Open-Label Study of Flexible-Dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.
  ClinicalTrials.gov Identifier: NCT00488319 - Recruiting
  Dementia Praecox.; Schizophrenia; Psychotic Disorders; Schizophrenic Disorders
  
• An Open-Label Extension Study With Flexible Dosing of Extended-Release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain
  ClinicalTrials.gov Identifier: NCT00487435 - Recruiting
  Low Back Pain; Pain; Osteoarthritis
  
• Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
  ClinicalTrials.gov Identifier: NCT00264615 - Completed
  Epilepsy
  
• Evaluation of Effectiveness and Safety of Flexible-Dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.
  ClinicalTrials.gov Identifier: NCT00412373 - Recruiting
  Psychotic Disorder; Schizoaffective Disorder
  
• Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder.
  ClinicalTrials.gov Identifier: NCT00397033 - Recruiting
  Schizoaffective Disorder; Psychotic Disorder
  
• Carbamazepine Extended-Release for the Treatment of Bipolar Depression
  ClinicalTrials.gov Identifier: NCT00203567 - Recruiting
  Bipolar Depression
  
• Extended Release Nifedipine Treatment as Maintenance Tocolysis to Prevent Preterm Delivery
  ClinicalTrials.gov Identifier: NCT00525486 - Not yet recruiting
  Preterm Labor
  
• A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back Pain
  ClinicalTrials.gov Identifier: NCT00449176 - Recruiting
  Low Back Pain
  
• A Phase III Trial to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
  ClinicalTrials.gov Identifier: NCT00421928 - Recruiting
  Pain; Osteoarthritis, Knee
  
• A Safety and Efficacy Study for Tapentadol (CG5503) Extended Release for Patients With Painful Diabetic Peripheral Neuropathy
  ClinicalTrials.gov Identifier: NCT00455520 - Recruiting
  Diabetic Polyneuropathy; Diabetic Neuropathy: Painful
  
• PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets
  ClinicalTrials.gov Identifier: NCT00491998 - Recruiting
  Parkinson's Disease
  
• The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients with Intermittent Claudication - TROPIC
  ClinicalTrials.gov Identifier: NCT00071266 - Completed
  Intermittent Claudication; Peripheral Vascular Disease
  
• A Study to Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00490971 - Recruiting
  Manic-Depressive Psychosis; Affective Disorder, Bipolar; Bipolar Disorder; Depression, Bipolar; Manic Disorder
  
• Enoximone Plus Extended-Release Metoprolol Succinate in Subjects with Advanced Chronic Heart Failure
  ClinicalTrials.gov Identifier: NCT00077948 - Active, not recruiting
  Heart Failure, Congestive
  
• Study to Compare the Effect of a Combination of Cetirizine With Pseudoephedrine Versus Placebo on Symptoms in Patients With Allergic Rhinitis Within/Out of Season
  ClinicalTrials.gov Identifier: NCT00474890 - Active, not recruiting
  Atopy; Rhinitis
  
• An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen
  ClinicalTrials.gov Identifier: NCT00344383 - Completed
  Metrorrhagia
  
• A Study to Look at the Efficacy and Safety of Keppra® Extended Release
  ClinicalTrials.gov Identifier: NCT00368069 - Completed
  Epilepsy
  
• A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol(CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain
  ClinicalTrials.gov Identifier: NCT00361504 - Active, not recruiting
  Osteoarthritis; Sciatica; Pain Assessment; Arthralgia
  
• Behavioral Naltrexone Therapy (BNT) for Promoting Adherence to Oral Naltrexone (BNT-Oral) vs Extended Release Injectable Depot Naltrexone (Depot-BNT); a Randomized Trial. A Free Treatment for Opiate Abuse.
  ClinicalTrials.gov Identifier: NCT00577408 - Recruiting
  Opiate Dependence; Heroin Dependence
  
• Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo
  ClinicalTrials.gov Identifier: NCT00283790 - Completed
  Insomnia
  
• Study Evaluating Venlafaxine Extended-Release in Depressed and Anxious Patients
  ClinicalTrials.gov Identifier: NCT00546923 - Completed
  Anxiety Disorders; Depression
  
• Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomania or Mild Mania
  ClinicalTrials.gov Identifier: NCT00278772 - Recruiting
  Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania
  
• Trial of Analgesia With Lidocaine or Extended-Release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00414453 - Not yet recruiting
  Neuropathic Pain; Chronic Pain; Multiple Sclerosis
  
• Antipsychotic Medication Extended Dosing Study
  ClinicalTrials.gov Identifier: NCT00431574 - Active, not recruiting
  Schizophrenia
  
• Clinical Performance of Extended Wear Silicone Hydrogel Lenses
  ClinicalTrials.gov Identifier: NCT00441233 - Active, not recruiting
  Myopia
  
• Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis
  ClinicalTrials.gov Identifier: NCT00492622 - Recruiting
  Gastroparesis; Gastroesophageal Reflux Disease
  
• An Effectiveness and Safety Study of Acetaminophen Extended Release Caplets in Treating Muscle Aches and Soreness That Occur After a Marathon Race
  ClinicalTrials.gov Identifier: NCT00240851 - Completed
  Pain
  
• Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00301236 - Completed
  ADHD, ADD
  
• A Study Comparing the Effectiveness and Safety of Extended Release Tramadol Versus Placebo for the Treatment of Osteoarthritis (OA) of the Knee
  ClinicalTrials.gov Identifier: NCT00348010 - Completed
  Chronic Pain
  
• A Study Comparing the Analgesic Efficacy and Safety of Extended Release Hydrocodone/Acetaminophen (Vicodin® CR)and Placebo in Subjects With Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00404183 - Completed
  Pain
  
• Extended Follow-up of Columbia, MO Serum Bank Participants
  ClinicalTrials.gov Identifier: NCT00340210 - Active, not recruiting
  Cancer; Morbidity
  
• Comparative Study of Modified Release (MR) Tacrolimus/MMF in de novo Kidney Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00064701 - Active, not recruiting
  Kidney Transplantation
  
• Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Diaologues Time to Talk Program
  ClinicalTrials.gov Identifier: NCT00401726 - Completed
  Depressive Disorder, Major
  
• Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and Over
  ClinicalTrials.gov Identifier: NCT00170768 - Completed
  Healthy Volunteers
  
• Study Evaluating Antibiotic Utilization Measures and Control of Extended-Spectrum-Lactamases (ESBLs)
  ClinicalTrials.gov Identifier: NCT00254696 - Active, not recruiting
  Bacterial Infection
  
• An Effectiveness and Safety Study of Acetaminophen Extended Release Caplets in the Treatment of Osteoarthritis of the Hip or Knee.
  ClinicalTrials.gov Identifier: NCT00240799 - Completed
  Osteoarthritis
  
• Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-Release) Compared With Quetiapine in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00334126 - Completed
  Schizophrenia
  
• A Study of Extended-Release Hydrocodone/Acetaminophen (Vicodin CR®) in Subjects With Acute Pain Following Bunionectomy
  ClinicalTrials.gov Identifier: NCT00402792 - Completed
  Pain
  
• An Effectiveness and Safety Study of Two Doses of Acetaminophen Extended Release Caplets in the Treatment of Osteoarthritis of the Hip or Knee
  ClinicalTrials.gov Identifier: NCT00240786 - Completed
  Osteoarthritis
  
• Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care
  ClinicalTrials.gov Identifier: NCT00345657 - Completed
  Hyperlipidemia; Mixed Hyperlipidemia; Dyslipidemia
  
• Open-Label Study to Evaluate the Efficacy and Safety of an Extended-Cycle, Low Dose Combination Oral Contraceptive
  ClinicalTrials.gov Identifier: NCT00196326 - Active, not recruiting
  Contraception
  
• Study Intended to Show That the VISTAKON Contact Lens is Safe and Effective for Use on an Extended-Wear Basis for Up to 7 Days and 6 Nights at a Time.
  ClinicalTrials.gov Identifier: NCT00241280 - Active, not recruiting
  Myopia
  
• A Randomised, Crossover Study Comparing the Biochemical and Platelet Effects of Modified-Release Dipyridamole/Aspirin (200mg/25 Mg Bd; Asasantin Retard®) with Aspirin (75 Mg Qd) in Coronary Artery Disease Patients with Aspirin Resistance Manifesting
  ClinicalTrials.gov Identifier: NCT00129038 - Active, not recruiting
  Coronary Arteriosclerosis
  
• An Open-Label Evaluation of the Dose Proportionality of OROS® Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg
  ClinicalTrials.gov Identifier: NCT00398957 - Active, not recruiting
  Analgesia
  
• A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's
  ClinicalTrials.gov Identifier: NCT00331149 - Recruiting
  Parkinson's Disease
  
• A Study Comparing the Analgesic Activity of Extended Release Hydrocodone/Acetaminophen (Vicodin® CR) and Placebo in Subjects With Pain Following Bunionectomy Surgery
  ClinicalTrials.gov Identifier: NCT00404391 - Completed
  Pain
  
• Phase III Study to Assess the Long Term Efficacy, Carry-Over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets
  ClinicalTrials.gov Identifier: NCT00418379 - Active, not recruiting
  Allergy